Logo image of DCGO

DOCGO INC (DCGO) Stock Fundamental Analysis

NASDAQ:DCGO - Nasdaq - US2560861096 - Common Stock - Currency: USD

4.88  +0.08 (+1.67%)

Fundamental Rating

6

DCGO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, its profitability is only average at the moment. DCGO is valued quite cheap, while showing a decent growth score. This is a good combination! This makes DCGO very considerable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DCGO had positive earnings in the past year.
DCGO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCGO reported negative net income in multiple years.
In the past 5 years DCGO reported 4 times negative operating cash flow.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

DCGO's Return On Assets of 6.24% is amongst the best of the industry. DCGO outperforms 87.96% of its industry peers.
DCGO's Return On Equity of 9.48% is fine compared to the rest of the industry. DCGO outperforms 77.78% of its industry peers.
With an excellent Return On Invested Capital value of 8.61%, DCGO belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DCGO is below the industry average of 8.15%.
The 3 year average ROIC (4.74%) for DCGO is below the current ROIC(8.61%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.24%
ROE 9.48%
ROIC 8.61%
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 4.44%, DCGO belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
DCGO's Operating Margin of 7.50% is fine compared to the rest of the industry. DCGO outperforms 75.00% of its industry peers.
The Gross Margin of DCGO (34.50%) is better than 61.11% of its industry peers.
In the last couple of years the Gross Margin of DCGO has declined.
Industry RankSector Rank
OM 7.5%
PM (TTM) 4.44%
GM 34.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DCGO is destroying value.
The number of shares outstanding for DCGO has been increased compared to 1 year ago.
The debt/assets ratio for DCGO is higher compared to a year ago.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 3.94 indicates that DCGO is not in any danger for bankruptcy at the moment.
DCGO has a Altman-Z score of 3.94. This is in the better half of the industry: DCGO outperforms 75.93% of its industry peers.
DCGO has a debt to FCF ratio of 1.02. This is a very positive value and a sign of high solvency as it would only need 1.02 years to pay back of all of its debts.
The Debt to FCF ratio of DCGO (1.02) is better than 90.74% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that DCGO is not too dependend on debt financing.
DCGO's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. DCGO outperforms 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.02
Altman-Z 3.94
ROIC/WACC0.98
WACC8.8%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

DCGO has a Current Ratio of 2.19. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a better Current ratio (2.19) than 76.85% of its industry peers.
DCGO has a Quick Ratio of 2.19. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a better Quick ratio (2.19) than 76.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.19
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 262.50% over the past year.
DCGO shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.17%.
Measured over the past years, DCGO shows a very strong growth in Revenue. The Revenue has been growing by 87.90% on average per year.
EPS 1Y (TTM)262.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)30.17%
Revenue growth 3Y87.9%
Revenue growth 5YN/A
Sales Q2Q%-25.66%

3.2 Future

Based on estimates for the next years, DCGO will show a very strong growth in Earnings Per Share. The EPS will grow by 36.36% on average per year.
Based on estimates for the next years, DCGO will show a decrease in Revenue. The Revenue will decrease by -9.76% on average per year.
EPS Next Y324.66%
EPS Next 2Y24.95%
EPS Next 3Y36.36%
EPS Next 5YN/A
Revenue Next Year0.95%
Revenue Next 2Y-17.78%
Revenue Next 3Y-9.76%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.83, the valuation of DCGO can be described as correct.
Based on the Price/Earnings ratio, DCGO is valued a bit cheaper than 79.63% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.28. DCGO is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 44.65, which means the current valuation is very expensive for DCGO.
DCGO's Price/Forward Earnings is on the same level as the industry average.
DCGO is valuated cheaply when we compare the Price/Forward Earnings ratio to 91.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.83
Fwd PE 44.65
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

93.52% of the companies in the same industry are more expensive than DCGO, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DCGO is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.56
EV/EBITDA 5.98
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DCGO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DCGO's earnings are expected to grow with 36.36% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y24.95%
EPS Next 3Y36.36%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DCGO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOCGO INC

NASDAQ:DCGO (1/30/2025, 9:35:57 AM)

4.88

+0.08 (+1.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners54%
Inst Owner Change0.64%
Ins Owners9.82%
Ins Owner Change7.61%
Market Cap498.00M
Analysts84.62
Price Target6.34 (29.92%)
Short Float %7.16%
Short Ratio10.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.79%
Min EPS beat(2)-8.5%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-4.64%
Min EPS beat(4)-31.37%
Max EPS beat(4)20.4%
EPS beat(8)3
Avg EPS beat(8)-47.91%
EPS beat(12)6
Avg EPS beat(12)72.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)-0.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)0.58%
Revenue beat(8)5
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)21.88%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)0%
EPS NY rev (3m)11.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.96%
Valuation
Industry RankSector Rank
PE 16.83
Fwd PE 44.65
P/S 0.72
P/FCF 11.56
P/OCF 9.66
P/B 1.53
P/tB 2.05
EV/EBITDA 5.98
EPS(TTM)0.29
EY5.94%
EPS(NY)0.11
Fwd EY2.24%
FCF(TTM)0.42
FCFY8.65%
OCF(TTM)0.5
OCFY10.35%
SpS6.81
BVpS3.19
TBVpS2.37
PEG (NY)0.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.24%
ROE 9.48%
ROCE 15.18%
ROIC 8.61%
ROICexc 11.32%
ROICexgc 15.97%
OM 7.5%
PM (TTM) 4.44%
GM 34.5%
FCFM 6.2%
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
ROICexc(3y)11.17%
ROICexc(5y)N/A
ROICexgc(3y)17.48%
ROICexgc(5y)N/A
ROCE(3y)7.8%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.02
Debt/EBITDA 0.57
Cap/Depr 49.23%
Cap/Sales 1.22%
Interest Coverage 33.07
Cash Conversion 74.33%
Profit Quality 139.73%
Current Ratio 2.19
Quick Ratio 2.19
Altman-Z 3.94
F-Score7
WACC8.8%
ROIC/WACC0.98
Cap/Depr(3y)69.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)262.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y324.66%
EPS Next 2Y24.95%
EPS Next 3Y36.36%
EPS Next 5YN/A
Revenue 1Y (TTM)30.17%
Revenue growth 3Y87.9%
Revenue growth 5YN/A
Sales Q2Q%-25.66%
Revenue Next Year0.95%
Revenue Next 2Y-17.78%
Revenue Next 3Y-9.76%
Revenue Next 5YN/A
EBIT growth 1Y243.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year296.97%
EBIT Next 3Y35.17%
EBIT Next 5YN/A
FCF growth 1Y66.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.1%
OCF growth 3YN/A
OCF growth 5YN/A